In the past, chemotherapy treatment was given to patients based on where in the body the cancer began, not taking in the factors of the molecular diversity of the individual patient’s cancer. Over the years, the development and advancement of the treatment for cancer has improved by applying molecular testing to determine individual patient tumors through DNA, RNA, and proteins.
As explained in a new article, “Precision medicine targets molecular features in cancer cells that are not in normal cells and it is now a focus of drug development,” says Timothy Cannon, MD, Director, Molecular Tumor Board Program and Co-Director, Gastrointestinal Cancer Program at the Inova Schar Cancer Institute. New strategies that modernize clinical trials and allow multiple drugs to be tested simultaneously have helped make progress with successful individualized treatment in cancer care.
Read the full article: “A Look at The Future of Targeted Therapy”
Inova Schar Cancer was among the trial’s leading-enrolling sites, with participation led by principal investigator…
Leesburg, VA – Inova Loudoun Hospital Mobile Health Services will be providing countywide blood pressure…
Also recognized for 9 “Exemplars” for top performance Leaders and team members celebrate Inova Mount…
New Prince William County location offers medical oncology, hematology, breast surgery, infusion and Inova Peterson…
Kathleen Harden, MD is a breast oncology physician, board-certified in medical oncology and internal medicine…
Dru Smith, an interstitial lung disease patient, shares his experience and care journey. Reston resident…